CD63 and cancer: In cancer, exosomes have been shown to carry specific proteins, such as CD63 and CD81, that are often upregulated in cancer cells, as well as specific miRNAs and mRNAs that can be used to monitor disease progression and treatment response (Mathew et al., 2021).